SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,499.17 -455.59
( -0.58%)

Global Indices

Nasdaq

54,056.75 150.65
(0.28%)

Dow Jones

7,778.11 47.15
(0.61%)

Hang Seng

65,597.55 -85.71
(-0.13%)

Nikkei 225

10,909.12 41.23
(0.38%)

Forex

USD-INR

95.20 0.13
(0.14%)

EUR-INR

109.83 0.08
(0.08%)

GBP-INR

128.13 0.14
(0.11%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

50.32

14307.31

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.55

Back

V I P Industries reports consolidated net loss of Rs 52.87 crore in the December 2025 quarter

Feb 15,2026

Net Loss of V I P Industries reported to Rs 52.87 crore in the quarter ended December 2025 as against net loss of Rs 12.42 crore during the previous quarter ended December 2024. Sales declined 9.37% to Rs 454.13 crore in the quarter ended December 2025 as against Rs 501.07 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	454.13	501.07	-9
OPM %	-16.92	5.71	-
PBDT	-89.50	13.34	PL
PBT	-121.48	-16.69	-628
NP	-52.87	-12.42	-326

78,499.17 -455.59 ( -0.58%)

54,056.75 150.65 (0.28%)

7,778.11 47.15 (0.61%)

65,597.55 -85.71 (-0.13%)

10,909.12 41.23 (0.38%)

95.20 0.13 (0.14%)

109.83 0.08 (0.08%)

128.13 0.14 (0.11%)

0.60 0.00 (-0.12%)